10th International Conference on gene therapy of cancer: 13 - 15 December 2001, San Diego, CA, USA.
This annual meeting was organised by R Sobol and A Deisseroth (Sidney Kimmel Cancer Center, San Diego, CA, USA) and K Scanlon (Keck Graduate Institute, Claremont, CA, USA). The meeting covered a wide range of topics in cancer gene therapy and included five sessions. The topics were: (1) Tumour suppressors/apoptosis/antisense-ribozymes/angiogenesis; (2) Vector systems; (3) Therapy sensitisation/'suicide' gene therapy; (4) Haematopoietic gene transfer; and (5) Poster/discussion sessions. The following meeting highlights have focused mainly on the recent progress in antisense/ribozyme-based approaches useful for cancer gene target validation and drug development.
Chen
Yin
Y
CytoGenix, Inc., 9881 S. Wilcrest Drive, Houston, TX 77584, USA. ychen@cytogenix.com
D004277:DNA, Single-Stranded / Q000096:biosynthesis / Q000235:genetics; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D016337:RNA, Catalytic / Q000627:therapeutic use
D004277:DNA, Single-Stranded; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic